CLINICAL
The TriGrid® Delivery System has been used for delivery of nucleic acid candidates encoding antigens, proteins and monoclonal antibodies in clinical stage programs in the U.S., E.U., U.K., Korea, and East Africa.
Clinical testing using the TriGrid for delivery has shown:
- Improved potency versus conventional injection demonstrated in randomized, placebo controlled trials
- DNA vaccines capable of eliciting cellular and humoral immune responses
- Preliminary indication of functional activity / disease modulation
Improved cellular response versus conventional injection demonstrated in randomized, placebo controlled trials
Vasan S, et al., PLoS One. 2011;6(5):e19252